旅行者腹泻

它是发展中国家腹泻发病和婴儿死亡的主要原因，也是旅行者腹泻与国家士兵腹泻的最常见病原菌。

It remains major causes of diarrheal morbidity and infant mortality in developing countries , and is also pathogenic bacteria for travelers diarrhea , and perennially associated with disease in soldiers deployed to developing countries .

在开发中国家旅行，约一半的人会罹患旅行者腹泻。

Traveler 's diarrhea affects up to half of people who travel to developing countries .

〔目的〕揭示我国当前出境旅行者腹泻（TD）的流行特征、规律及其对经济造成损失的情况，科学地指导我国国际旅行卫生保健工作。

Objective To probe the current epidemiological characters and rules of diarrhea ( TD ) among Chinese outbound travelers , and estimate its economic loss for providing scientific guidance on international travel health care .

利福昔明预防旅行者腹泻：一项随机、双盲、安慰剂对照试验

A randomized , double-blind , placebo-controlled trial of rifaximin to prevent travelers ' diarrhea

本文对感染性腹泻及其病原体、临床症状，感染性腹泻传播途径和传播媒介进行论述，提出了，要控制旅行者腹泻，首先应从旅行者自身作起，增强自我保护意识；

This paper discussed infection diarrhea and pathogen , clinical manifestation , vehicle of disease .

它导致数以万计的人们尤其是发展中国家的婴幼儿腹泻，同时它也是旅行者腹泻的最常见病原菌。

It causes thousands of people diarrhea especially infants in developing countries , and associates with travelers ' diarrhea .

它介绍了在到墨西哥旅行的美国学生中，使用这些药片如何大大降低了旅行者的腹泻风险。

The study described how using these tablets greatly reduced the risk of traveler 's diarrhea among American students traveling to Mexico .

旅行者感染性腹泻的控制

The Diarrhea of Traveller and Control